Why is that? Well, for starters it has already been able to show that its 2-peptide and 7-peptide ELI-002 vaccine is capable of being able to target metastatic KRAS mutant solid tumor patients.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. In a fresh appearance on CNBC’s Squawk on the Street, Jim Cramer cautioned ...

Washington State Rep. Marilyn Strickland has joined California representatives Young Kim and Dave Min in reintroducing a bipartisan bill to award the Congressional Gold Medal to Colonel Young Oak Kim ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. Full text is unavailable for this digitized archive article. Subscribers may view the full text of this article in ...

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

A family insider told The Mirror: "You have to remember that they were both young parents when they had Lilly, so while [it is] a surprise, it's not as big a deal for them as it might be for others." ...

After Israel Defense Forces Chief of Staff Lt. Gen. Herzi Halevi announced his resignation, Defense Minister Israel Katz on Wednesday notified three senior Israeli generals that they were ...